Laboratorios Farmaceuticos ROVI Long-term Investment Intensity
Laboratorios Farmaceuticos ROVI long-term investment intensity. Laboratorios Farmaceuticos ROVI (ROVI) has a Long-term Investment Intensity of 0.4% as of December 2019. Long-term investments of €1.91 Million represent 0.4% of total assets of €511.21 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Laboratorios Farmaceuticos ROVI short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Laboratorios Farmaceuticos ROVI (2013–2019)
Long-term investment intensity of Laboratorios Farmaceuticos ROVI from 2013 to 2019. This chart shows how Laboratorios Farmaceuticos ROVI's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.4%, reflecting long-term investments of €1.91 Million against total assets of €511.21 Million EUR. See Laboratorios Farmaceuticos ROVI defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Laboratorios Farmaceuticos ROVI Long-term Investment Intensity by Year (2013–2019)
Laboratorios Farmaceuticos ROVI long-term investment intensity by year from 2013 to 2019. The table below presents the year-by-year Long-term Investment Intensity for Laboratorios Farmaceuticos ROVI from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Laboratorios Farmaceuticos ROVI.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.4% | €1.91 Million | €511.21 Million | ▼ -0.1 pp |
| 2018 | 0.5% | €2.11 Million | €402.70 Million | ▼ -0.2 pp |
| 2017 | 0.7% | €2.12 Million | €298.38 Million | ▼ -0.2 pp |
| 2016 | 0.9% | €2.64 Million | €287.85 Million | ▲ +0.9 pp |
| 2015 | 0.0% | €70.00K | €263.85 Million | ▼ 0.0 pp |
| 2014 | 0.0% | €71.00K | €261.32 Million | ▼ -6.8 pp |
| 2013 | 6.8% | €16.12 Million | €235.92 Million | — |